相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibition of MCL1 induces apoptosis in anaplastic large cell lymphoma and in primary effusion lymphoma
Hilmar Quentmeier et al.
SCIENTIFIC REPORTS (2022)
The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs
Sarah T. Diepstraten et al.
NATURE REVIEWS CANCER (2022)
Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen dysregulates expression of MCL-1 by targeting FBW7
Yeong Jun Kim et al.
PLOS PATHOGENS (2021)
Long-term Follow-up of Patients with Relapsed or Refractory Non-Hodgkin Lymphoma Treated with Venetoclax in a Phase I, First-in-Human Study
Matthew S. Davids et al.
CLINICAL CANCER RESEARCH (2021)
USP7-Dependent Regulation of TRAF Activation and Signaling by a Viral Interferon Regulatory Factor Homologue
Qiwang Xiang et al.
JOURNAL OF VIROLOGY (2020)
How intrinsic and extrinsic regulators of plasma cell survival might intersect for durable humoral immunity
Marcus J. Robinson et al.
IMMUNOLOGICAL REVIEWS (2020)
Global epigenomic analysis of KSHV-infected primary effusion lymphoma identifies functional MYC superenhancers and enhancer RNAs
Angela Park et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Kaposi's Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma
Mark Manzano et al.
MBIO (2020)
Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors
Chong Wang et al.
NATURE COMMUNICATIONS (2020)
Cell Model Passportsa hub for clinical, genetic and functional datasets of preclinical cancer models
Dieudonne van der Meer et al.
NUCLEIC ACIDS RESEARCH (2019)
Viral, immunologic, and clinical features of primary effusion lymphoma
Kathryn Lurain et al.
BLOOD (2019)
The Interaction between ORF18 and ORF30 Is Required for Late Gene Expression in Kaposi's Sarcoma-Associated Herpesvirus
Angelica F. Castaneda et al.
JOURNAL OF VIROLOGY (2019)
KSHV activates unfolded protein response sensors but suppresses downstream transcriptional responses to support lytic replication
Benjamin P. Johnston et al.
PLOS PATHOGENS (2019)
CK1 alpha and IRF4 are essential and independent effectors of immunomodulatory drugs in primary effusion lymphoma
Ajinkya Patil et al.
BLOOD (2018)
Human Herpesvirus 8 Interferon Regulatory Factors 1 and 3 Mediate Replication and Latency Activities via Interactions with USP7 Deubiquitinase
Qiwang Xiang et al.
JOURNAL OF VIROLOGY (2018)
Dynamic Regulation of Long-Chain Fatty Acid Oxidation by a Noncanonical Interaction between the MCL-1 BH3 Helix and VLCAD
Silvia Escudero et al.
MOLECULAR CELL (2018)
Metabolic Links between Plasma Cell Survival, Secretion, and Stress
Wing Y. Lam et al.
TRENDS IN IMMUNOLOGY (2018)
Gene essentiality landscape and druggable oncogenic dependencies in herpesviral primary effusion lymphoma
Mark Manzano et al.
NATURE COMMUNICATIONS (2018)
Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Matthew S. Davids et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Prediction of potent shRNAs with a sequential classification algorithm
Raphael Pelossof et al.
NATURE BIOTECHNOLOGY (2017)
Deregulation of KSHV latency conformation by ER- stress and caspase- dependent RAD21-cleavage
Alessandra De Leo et al.
PLOS PATHOGENS (2017)
Defining a Cancer Dependency Map
Aviad Tsherniak et al.
CELL (2017)
Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors
R. Gopalakrishnan et al.
ONCOGENE (2016)
The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
Andras Kotschy et al.
NATURE (2016)
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
John G. Doench et al.
NATURE BIOTECHNOLOGY (2016)
Blimp-1 controls plasma cell function through the regulation of immunoglobulin secretion and the unfolded protein response
Julie Tellier et al.
NATURE IMMUNOLOGY (2016)
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
Andrew W. Roberts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia
Marina Konopleva et al.
CANCER DISCOVERY (2016)
Gammaherpesviruses and Lymphoproliferative Disorders
Ethel Cesarman
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 9 (2014)
Building blocks of the apoptotic pore: how Bax and Bak are activated and oligomerize during apoptosis
D. Westphal et al.
CELL DEATH AND DIFFERENTIATION (2014)
DNASU plasmid and PSI: Biology-Materials repositories: resources to accelerate biological research
Catherine Y. Seiler et al.
NUCLEIC ACIDS RESEARCH (2014)
Role of Human Herpesvirus 8 Interleukin-6-Activated gp130 Signal Transducer in Primary Effusion Lymphoma Cell Growth and Viability
Emily Cousins et al.
JOURNAL OF VIROLOGY (2013)
Mcl-1 is essential for the survival of plasma cells
Victor Peperzak et al.
NATURE IMMUNOLOGY (2013)
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran et al.
NATURE PROTOCOLS (2013)
Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapy
Samuel K. McBrayer et al.
BLOOD (2012)
Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration
Rhonda M. Perciavalle et al.
NATURE CELL BIOLOGY (2012)
Tumor suppressor genes FHIT and WWOX are deleted in primary effusion lymphoma (PEL) cell lines
Debasmita Roy et al.
BLOOD (2011)
MCL-1 is a stress sensor that regulates autophagy in a developmentally regulated manner
Marc Germain et al.
EMBO JOURNAL (2011)
Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas
Aadra P. Bhatt et al.
BLOOD (2010)
BH3 mimetics antagonizing restricted prosurvival Bcl-2 proteins represent another class of selective immune modulatory drugs
Emma M. Carrington et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Mcl-1 Is Essential for Germinal Center Formation and B Cell Memory
Ingela Vikstrom et al.
SCIENCE (2010)
NF-κB signaling modulation by EBV and KSHV
Deilson Elgui de Oliveira et al.
TRENDS IN MICROBIOLOGY (2010)
Intracellular Signaling Mechanisms and Activities of Human Herpesvirus 8 Interleukin-6
Daming Chen et al.
JOURNAL OF VIROLOGY (2009)
Key role for Bak activation and Bak-Bax interaction in the apoptotic response to vinblastine
Meenakshi Upreti et al.
MOLECULAR CANCER THERAPEUTICS (2008)
The viral interferon-regulatory factor-3 is required for the survival of KSHV-infected primary effusion lymphoma cells
Effi Wies et al.
BLOOD (2008)
Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen
D. Bubman et al.
ONCOGENE (2007)
Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas
Grzegorz Sarek et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling
Sang-Hoon Sin et al.
BLOOD (2007)
Functional p53 signaling in Kaposi's sarcoma-associated herpesvirus lymphomas: Implications for therapy
Christin E. Petre et al.
JOURNAL OF VIROLOGY (2007)
Inhibiting primary effusion lymphoma, by lentiviral vectors encoding short hairpin RNA
A Godfrey et al.
BLOOD (2005)
Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association
W Fan et al.
JOURNAL OF VIROLOGY (2005)
Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma
HW Wang et al.
NATURE GENETICS (2004)
Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a gene expression profile
RG Jenner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts
U Klein et al.
BLOOD (2003)
Expression of MUM1/IRF4 selectively clusters with primary effusion lymphoma among lymphomatous effusions: implications for disease histogenesis and pathogenesis
A Carbone et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
分享论文
